U.S. markets close in 5 hours 49 minutes
  • S&P 500

    4,224.13
    -0.66 (-0.02%)
     
  • Dow 30

    33,811.08
    -65.89 (-0.19%)
     
  • Nasdaq

    14,144.03
    +2.55 (+0.02%)
     
  • Russell 2000

    2,269.04
    -17.06 (-0.75%)
     
  • Crude Oil

    73.75
    +0.09 (+0.12%)
     
  • Gold

    1,775.30
    -7.60 (-0.43%)
     
  • Silver

    25.84
    -0.18 (-0.69%)
     
  • EUR/USD

    1.1909
    -0.0016 (-0.13%)
     
  • 10-Yr Bond

    1.4950
    +0.0110 (+0.74%)
     
  • GBP/USD

    1.3903
    -0.0030 (-0.21%)
     
  • USD/JPY

    110.6500
    +0.3520 (+0.32%)
     
  • BTC-USD

    29,226.33
    -3,812.17 (-11.54%)
     
  • CMC Crypto 200

    694.00
    -100.32 (-12.63%)
     
  • FTSE 100

    7,078.89
    +16.60 (+0.24%)
     
  • Nikkei 225

    28,884.13
    +873.20 (+3.12%)
     

3 Stocks With Low Forward Price-Earnings Ratios

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

To increase the likelihood to uncover value opportunities, investors may want to consider stocks with a favorable forward price-earnings ratio. The following stocks have a forward price-earnings ratio (based on Morningstar analysts' earnings estimates) that is lower than the S&P 500 index's historical average of 15.

NextGen Healthcare Inc

The first company under consideration is NextGen Healthcare Inc (NASDAQ:NXGN), an Irvine, California-based provider of healthcare software and services solutions to clinics in the U.S.


NextGen Healthcare has a forward price-earnings ratio of 13.4 (versus the industry median of 25.19), which results from Friday's share price of $9.78 and analyst expectations of EPS of 73 cents for the next full fiscal year.

The stock price has decreased 49.4% in the past year for a market cap of $642.56 million and a 52-week range of $5.10 to $21.12.

GuruFocus has assigned a good rating of 7 out of 10 to the company's financial strength and a positive rating of 6 out of 10 to its profitability.

The stock has a hold recommendation rating on Wall Street and an average target price of $11.46.

Perrigo Co PLC

The second company to consider is Perrigo Co PLC (NYSE:PRGO), an Irish manufacturer and supplier of over-the-counter health and wellbeing solutions in the U.S. and internationally.

Perrigo Co has a forward price-earnings ratio of 13.74 (versus the industry median of 18.69), which is the result of a share price of $54.28 as of May 22 and analyst expectations of $3.95 in EPS for the next full fiscal year.

The share price rose by 14.6% in the past year. The stock has a market capitalization of $7.4 billion and a 52-week range of $40.10 to $63.86.

GuruFocus has assigned a moderate rating of 4 out of 10 to the company's financial strength and a positive rating of 6 out of 10 to its profitability.

The stock has an overweight recommendation rating on Wall Street and an average target price of $57.56.

Flex Ltd

The third company to consider is Flex Ltd (NASDAQ:FLEX), a Singapore-based provider of design, manufacturing and supply chain services to original equipment manufacturers worldwide.

Flex has a forward price-earnings ratio of 8.66 (versus the industry median of 16.25), which is the result of a share price of $9.61 as of May 22 and analyst expectations of EPS of $1.11 for the next full fiscal year.

The stock price has risen by almost 4% in the past year for a market cap of $4.84 billion and a 52-week range of $5.36 to $14.

GuruFocus has assigned a positive rating of 6 out of 10 to both the company's financial strength and its profitability.

The stock has an overweight recommendation rating on Wall Street and an average target price of $12.69 per share.

Disclosure: I have no positions in any securities mentioned in this article.

Read more here:



Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.

This article first appeared on GuruFocus.